Myleukomanoblastic leukemia is a type of malignant bone marrow disease characterized by abnormal growth of blood cells. It begins when the bone marrow produces too many or the wrong shapes of white blood cells called leukocytes. These cells are supposed to serve a protective function in the body, but in myleiomanoblastic leukemia they become uncontrollable and begin to spread throughout the body.
The most common symptoms of this disease include:
1. Fatigue and weakness. 2. Loss of appetite. 3. Constant bone pain. 4. Irritable changes in the skin and mucous membranes. 5. Anemia (low red blood cell count), which can cause dizziness and fatigue. 6. Anxiety and depression can also be signs of leukemia, as patients risk losing limbs or other organs.
Treatment of myleukomanoblastic leukemia is based on chemotherapy and stem cell transplantation. It does not cure the disease, but only prolongs the life of patients and helps them improve their quality of life. Patients with this type of leukemia often experience serious side effects